Free tool
FAERS Monitor: Daybue
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 217026 or its brand name (Daybue, Trofinetide). Reports on generic versions are filed under their own applications.
Reports
6,891
Serious
2,007
29% of reports
Hospitalization
840
Death reported
42
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea3,750
- underdose2,082
- vomiting1,187
- product dose omission issue909
- seizure882
- constipation700
- product use complaint655
- weight decreased609
- intentional dose omission484
- drug ineffective481
- decreased appetite424
- nasopharyngitis389
- flatulence378
- inappropriate schedule of product administration358
- faeces soft352
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2020 | 1 |
| 2023 | 1,120 |
| 2024 | 1,820 |
| 2025 | 2,524 |
| 2026 | 1,426 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,268 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| faeces softSignal | 352 | 155.2 | 139.8 | 51,187 |
| product use complaintSignal | 655 | 132.4 | 122.8 | 81,778 |
| underdoseSignal | 2,082 | 89.6 | 86.4 | 177,696 |
| intentional dose omissionSignal | 484 | 52.7 | 48.3 | 24,110 |
| seizureSignal | 882 | 23.5 | 22.1 | 18,918 |
| flatulenceSignal | 378 | 20.5 | 18.6 | 6,954 |
| diarrhoeaSignal | 3,750 | 17.8 | 17.4 | 61,083 |
| constipationSignal | 700 | 9.8 | 9.2 | 5,580 |
| product dose omission issueSignal | 909 | 9.5 | 8.9 | 6,946 |
| vomitingSignal | 1,187 | 7.7 | 7.3 | 7,081 |
| weight decreasedSignal | 609 | 6.7 | 6.2 | 2,963 |
| nasopharyngitisSignal | 389 | 6.5 | 5.9 | 1,799 |
| inappropriate schedule of product administrationSignal | 358 | 6.1 | 5.5 | 1,522 |
| decreased appetiteSignal | 424 | 5.6 | 5.1 | 1,604 |
| drug ineffective | 481 | 1.1 | 1.0 | 6 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.